Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Bright Minds Biosciences Inc
C.DRUG
Alternate Symbol(s):
DRUG
Healthcare
Biotechnology
Bright Minds Biosciences Inc. is a biotechnology company, which is engaged in developing treatments for patients with neurological and psychiatric disorders. The Company is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and...
modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:DRUG)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(35)
•••
johnnydang
X
Post by
johnnydang
on May 13, 2025 12:45pm
Time to start buying again
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101: https://stockhouse.com/news/press-releases/2025/05/13/bright-minds-biosciences-announces
...more
(2)
•••
loaddumper
X
Post by
loaddumper
on Mar 06, 2025 8:36am
looks like our partner Firefly is at it again.....
https://www.newsfilecorp.com/release/243458
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 26, 2024 8:59am
DRUG....Now how resilient can it be
Over $40 ...again Sheesh
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 21, 2024 9:00am
New Press Release - Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
- Poster presentations on BMB-101 will focus on 5-HT2C functional selectivity and Phase 1 clinical data -NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug...
read article.
(1)
•••
Investor10X
X
Comment by
Investor10X
on Nov 11, 2024 3:35pm
RE:RE:RE:3 Hot Biotech Stocks to Watch $DRUG $NRX $BIOV
There's no doubt that a high short counts that needs to be covered on a buying spree by investors shoots a stock into the stratosphere. However, finding decent stocks with great news that
...more
(107)
•••
Iseneschal
X
Comment by
Iseneschal
on Nov 07, 2024 3:52pm
RE:Mathieu Martin - Stocks and Stones - The Good, The Bad......
Bright Minds share price has certainly surpassed anyones expectations......especially all those that shorted it ; ) I may as well pump my own book here because DRUG did a collaboration deal with a US
...more
(1801)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Nov 07, 2024 9:51am
Mathieu Martin - Stocks and Stones - The Good, The Bad......
I was unsure which category to put this one in. On October 15, the shares of Bright Minds Biosciences (CSE: DRUG) went parabolic on seemingly no news. And when I say parabolic, I mean a 25 times
...more
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2024 10:25am
DRUG...what can u say about this deal
Made it's sh holders a ton of money... then again.....killed all the Shorts....literally !!!!
(35)
•••
johnnydang
X
Post by
johnnydang
on Nov 05, 2024 9:59am
Up 12%
We hit $78 That PP news is hitting the spot.
(35)
•••
johnnydang
X
Post by
johnnydang
on Nov 05, 2024 2:09am
Big 35 Million PP Closed
Let the games begin...
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 04, 2024 2:41pm
New Press Release - Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces that further to its news release of October 18, 2024, the Company has closed a non-brokered private placement of 1,612,902 common...
read article.
(2389)
•••
quinlash
X
Post by
quinlash
on Oct 31, 2024 1:58pm
RE:RE:3 Hot Biotech Stocks to Watch $DRUG $NRX $BIOV
The trick to finding stocks that make these sorts of rapid / massive runs is to buy on stocks that have high short positions. It takes time to form so long hold times are a necessity. Shorts are
...more
(1)
•••
Investor10X
X
Comment by
Investor10X
on Oct 21, 2024 1:13pm
RE:3 Hot Biotech Stocks to Watch $DRUG $NRX $BIOV
I would be inclined to add PharmAla biotech (Symbol: MDMA or MDXXf) to that list. The company has signed multiple contracts with high profile hospitals and universities (John Hopkins, Harvard
...more
(10)
•••
Mathew177
X
Post by
Mathew177
on Oct 21, 2024 11:13am
3 Hot Biotech Stocks to Watch $DRUG $NRX $BIOV
3 Hot Biotech Stocks to Watch $DRUG $NRX $BIOV https://10xalerts.com/3-hot-biotech-stocks-to-watch/
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 21, 2024 8:30am
New Press Release - Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, today announced that it is once...
read article.
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Identifying new compelling targets on extensive and highly prospective land position
Developing a sizeable copper resource with a highly prospective exploration asset in Peru